German American Bancorp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.95M | Buy |
140,836
+12,368
| +10% | +$329K | 0.34% | 50 |
|
|
2025
Q4 | $3.2M | Sell |
128,468
-7,644
| -6% | -$193K | 0.27% | 56 |
|
|
2025
Q3 | $3.47M | Buy |
136,112
+6,021
| +5% | +$149K | 0.31% | 53 |
|
|
2025
Q2 | $3.15M | Sell |
130,091
-2,138
| -2% | -$49.9K | 0.31% | 55 |
|
|
2025
Q1 | $3.35M | Buy |
132,229
+25,441
| +24% | +$666K | 0.36% | 53 |
|
|
2024
Q4 | $2.83M | Sell |
106,788
-34,647
| -24% | -$940K | 0.3% | 54 |
|
|
2024
Q3 | $4.09M | Buy |
141,435
+12,423
| +10% | +$362K | 0.43% | 46 |
|
|
2024
Q2 | $3.61M | Buy |
129,012
+3,728
| +3% | +$103K | 0.41% | 48 |
|
|
2024
Q1 | $3.48M | Buy |
125,284
+37,124
| +42% | +$1.03M | 0.42% | 51 |
|
|
2023
Q4 | $2.54M | Sell |
88,160
-45,501
| -34% | -$1.38M | 0.33% | 53 |
|
|
2023
Q3 | $4.43M | Sell |
133,661
-1,687
| -1% | -$59.7K | 0.64% | 40 |
|
|
2023
Q2 | $4.96M | Buy |
135,348
+1,119
| +0.8% | +$43.6K | 0.7% | 37 |
|
|
2023
Q1 | $5.48M | Sell |
134,229
-3,466
| -3% | -$150K | 0.82% | 31 |
|
|
2022
Q4 | $7.06M | Sell |
137,695
-1,050
| -0.8% | -$50.3K | 1.12% | 25 |
|
|
2022
Q3 | $6.07M | Buy |
138,745
+8,809
| +7% | +$428K | 1.05% | 23 |
|
|
2022
Q2 | $6.81M | Sell |
129,936
-6,585
| -5% | -$336K | 1.15% | 19 |
|
|
2022
Q1 | $7.07M | Sell |
136,521
-73
| -0.1% | -$3.79K | 1.03% | 26 |
|
|
2021
Q4 | $8.07M | Buy |
136,594
+2,325
| +2% | +$115K | 1.13% | 24 |
|
|
2021
Q3 | $5.78M | Buy |
134,269
+4,539
| +3% | +$201K | 0.89% | 32 |
|
|
2021
Q2 | $5.08M | Buy |
129,730
+5,850
| +5% | +$227K | 0.8% | 34 |
|
|
2021
Q1 | $4.49M | Buy |
123,880
+8,966
| +8% | +$318K | 0.78% | 36 |
|
|
2020
Q4 | $4.23M | Buy |
114,914
+4,019
| +4% | +$147K | 0.83% | 34 |
|
|
2020
Q3 | $3.86M | Buy |
110,895
+54,291
| +96% | +$1.9M | 0.95% | 29 |
|
|
2020
Q2 | $1.76M | Buy |
56,604
+582
| +1% | +$19.8K | 0.46% | 44 |
|
|
2020
Q1 | $1.73M | Buy |
56,022
+552
| +1% | +$18.8K | 0.51% | 45 |
|
|
2019
Q4 | $2.06M | Buy |
55,470
+246
| +0.4% | +$8.76K | 0.5% | 47 |
|
|
2019
Q3 | $1.88M | Buy |
55,224
+2,405
| +5% | +$87.5K | 0.5% | 48 |
|
|
2019
Q2 | $2.17M | Buy |
52,819
+2,389
| +5% | +$94.9K | 0.59% | 43 |
|
|
2019
Q1 | $2.03M | Buy |
50,430
+2,340
| +5% | +$93.7K | 0.6% | 44 |
|
|
2018
Q4 | $1.99M | Buy |
48,090
+1,712
| +4% | +$71.1K | 0.66% | 42 |
|
|
2018
Q3 | $1.94M | Sell |
46,378
-739
| -2% | -$28.4K | 0.58% | 47 |
|
|
2018
Q2 | $1.62M | Buy |
+47,117
| New | +$1.61M | 0.51% | 51 |
|
Other funds holding PFE
VCM
VPM
German American Bancorp's PFE Position: Q1 2026 in Review
German American Bancorp increased its Pfizer (PFE) stake by 9.6% in Q1 2026, buying an estimated $329K and bringing the position to 140,836 shares worth $3.95M. The position accounts for 0.34% of the portfolio, ranked #50.
German American Bancorp first reported a position in PFE in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.07M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- German American Bancorp held 140,836 shares of Pfizer worth $3.95M as of Q1 2026.
- German American Bancorp bought 12,368 Pfizer shares in Q1 2026, an estimated $329K.
- Pfizer made up 0.34% of German American Bancorp's portfolio in Q1 2026, its #50 holding.
- German American Bancorp first reported a position in Pfizer in Q2 2018 and has held it in 32 quarters since.
- German American Bancorp's Pfizer position peaked at $8.07M in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on German American Bancorp's 13F filing for Q1 2026, filed 6 May 2026.